"The U.S. Food and Drug Administration today approved Dotarem (gadoterate meglumine) for use in magnetic resonance imaging (MRI) of the brain, spine and associated tissues of patients ages 2 years and older.
Dotarem is a gadolinium-based"...
Manifestations of Overdosage
Observed in normal subjects only: dizziness, blurred vision, diplopia, headache, impaired accommodation, nausea, slight tachycardia. In therapy it has been difficult to differentiate side effects due to the drug from those due to the effects of the poison.
There are no known absolute contraindications for the use of PROTOPAM (see PRECAUTIONS: DRUG INTERACTIONS and DOSAGE AND ADMINISTRATION). Relative contraindications include known hypersensitivity to the drug and other situations in which the risk of its use clearly outweighs possible benefit.
Last reviewed on RxList: 10/13/2010
This monograph has been modified to include the generic and brand name in many instances.
Additional Protopam Information
Report Problems to the Food and Drug Administration
Find out what women really need.